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There are important challenges in the application of
cost-effectiveness analysis results in the real world that
highlight the great divide between academic research
and practical application. The difficulty is magnified in
cancer because of the intense emotions it raises and
their influence on decision making, impacting treatment
funding decisions. Nevertheless, the potential for cost-
effectiveness analysis to inform policy decisions is also
great.
In 2007, Cancer Care Ontario (CCO) established
Canada’s first in-house Pharmacoeconomics Research
Unit comprised of independent researchers. This pre-
sentation reviews the initial five years of the Pharmacoe-
conomics Research Unit at CCO. The purpose is to
share lessons and point out directions for future
research in cost-effectiveness analysis aimed at inform-
ing decision makers in the real world.
To enrich the evidence base, we must continue to
develop and apply new methods of analyzing data and
displaying information. We must also face the reality that
the purpose of our role may be to promote goals related
to process rather than outcome, suggesting that getting
the question of interest right may be more important for
researchers than correctly solving the wrong problem.
Creating the best estimate of cost-effectiveness is not
knowledge for knowledge’s sake; this type of information
is the foundation of accountability and sustainability.
There is great potential for methods from health eco-
nomics to provide useful information; it is possible for
the results of our analysis to be understood and used by
policy makers and other decision makers in the real
world. Experiences at the Pharmacoeconomics Research
Unit have illustrated this potential.
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